Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival.

Pu X, Storr SJ, Zhang Y, Rakha EA, Green AR, Ellis IO, Martin SG.

Apoptosis. 2017 Mar;22(3):357-368. doi: 10.1007/s10495-016-1323-5.

2.

The calpain system is associated with survival of breast cancer patients with large but operable inflammatory and non-inflammatory tumours treated with neoadjuvant chemotherapy.

Storr SJ, Zhang S, Perren T, Lansdown M, Fatayer H, Sharma N, Gahlaut R, Shaaban A, Martin SG.

Oncotarget. 2016 Jul 26;7(30):47927-47937. doi: 10.18632/oncotarget.10066.

3.

Immunohistochemical Assessment of Leukocyte Involvement in Angiogenesis.

Ahmad NS, Martin SG, Storr SJ.

Methods Mol Biol. 2016;1430:49-57. doi: 10.1007/978-1-4939-3628-1_3.

PMID:
27172945
4.

Calpain-1 is associated with adverse relapse free survival in breast cancer: a confirmatory study.

Pu X, Storr SJ, Ahmad NS, Chan SY, Moseley PM, Televantou D, Cresti N, Boddy A, Ellis IO, Martin SG.

Histopathology. 2016 Jun;68(7):1021-9. doi: 10.1111/his.12896.

PMID:
26496999
5.

Calpain in Breast Cancer: Role in Disease Progression and Treatment Response.

Storr SJ, Thompson N, Pu X, Zhang Y, Martin SG.

Pathobiology. 2015 Sep;82(3-4):133-41. doi: 10.1159/000430464. Review.

PMID:
26330354
6.

FKBPL: a marker of good prognosis in breast cancer.

Nelson L, McKeen HD, Marshall A, Mulrane L, Starczynski J, Storr SJ, Lanigan F, Byrne C, Arthur K, Hegarty S, Ali AA, Furlong F, McCarthy HO, Ellis IO, Green AR, Rakha E, Young L, Kunkler I, Thomas J, Jack W, Cameron D, Jirström K, Yakkundi A, McClements L, Martin SG, Gallagher WM, Dunn J, Bartlett J, O'Connor D, Robson T.

Oncotarget. 2015 May 20;6(14):12209-23.

7.

Low calpain-9 is associated with adverse disease-specific survival following endocrine therapy in breast cancer.

Davis J, Martin SG, Patel PM, Green AR, Rakha EA, Ellis IO, Storr SJ.

BMC Cancer. 2014 Dec 23;14:995. doi: 10.1186/1471-2407-14-995.

8.

Involvement of metformin and AMPK in the radioresponse and prognosis of luminal versus basal-like breast cancer treated with radiotherapy.

Zhang Y, Storr SJ, Johnson K, Green AR, Rakha EA, Ellis IO, Morgan DA, Martin SG.

Oncotarget. 2014 Dec 30;5(24):12936-49.

9.

Expression of the calpain system is associated with poor clinical outcome in gastro-oesophageal adenocarcinomas.

Storr SJ, Pu X, Davis J, Lobo D, Reece-Smith AM, Parsons SL, Madhusudan S, Martin SG.

J Gastroenterol. 2013 Nov;48(11):1213-21. doi: 10.1007/s00535-012-0743-4.

PMID:
23329366
10.

Redox environment, free radical, and oxidative DNA damage.

Storr SJ, Woolston CM, Zhang Y, Martin SG.

Antioxid Redox Signal. 2013 Jun 20;18(18):2399-408. doi: 10.1089/ars.2012.4920. Review.

PMID:
23249296
11.

A comparative study of adhesion of melanoma and breast cancer cells to blood and lymphatic endothelium.

Safuan S, Storr SJ, Patel PM, Martin SG.

Lymphat Res Biol. 2012 Dec;10(4):173-81. doi: 10.1089/lrb.2012.0007.

12.

Calpain system protein expression in carcinomas of the pancreas, bile duct and ampulla.

Storr SJ, Zaitoun AM, Arora A, Durrant LG, Lobo DN, Madhusudan S, Martin SG.

BMC Cancer. 2012 Nov 9;12:511. doi: 10.1186/1471-2407-12-511.

13.

Calpain system protein expression in basal-like and triple-negative invasive breast cancer.

Storr SJ, Lee KW, Woolston CM, Safuan S, Green AR, Macmillan RD, Benhasouna A, Parr T, Ellis IO, Martin SG.

Ann Oncol. 2012 Sep;23(9):2289-96. doi: 10.1093/annonc/mds176.

14.

The prognostic and predictive power of redox protein expression for anthracycline-based chemotherapy response in locally advanced breast cancer.

Woolston CM, Zhang L, Storr SJ, Al-Attar A, Shehata M, Ellis IO, Chan SY, Martin SG.

Mod Pathol. 2012 Aug;25(8):1106-16. doi: 10.1038/modpathol.2012.60.

15.

Calpain-2 expression is associated with response to platinum based chemotherapy, progression-free and overall survival in ovarian cancer.

Storr SJ, Safuan S, Woolston CM, Abdel-Fatah T, Deen S, Chan SY, Martin SG.

J Cell Mol Med. 2012 Oct;16(10):2422-8. doi: 10.1111/j.1582-4934.2012.01559.x.

16.

Base excision repair, the redox environment and therapeutic implications.

Storr SJ, Woolston CM, Martin SG.

Curr Mol Pharmacol. 2012 Jan;5(1):88-101. Review.

PMID:
22122466
17.

Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma.

Storr SJ, Safuan S, Mitra A, Elliott F, Walker C, Vasko MJ, Ho B, Cook M, Mohammed RA, Patel PM, Ellis IO, Newton-Bishop JA, Martin SG.

Mod Pathol. 2012 Apr;25(4):493-504. doi: 10.1038/modpathol.2011.182.

18.

Expression of thioredoxin system and related peroxiredoxin proteins is associated with clinical outcome in radiotherapy treated early stage breast cancer.

Woolston CM, Storr SJ, Ellis IO, Morgan DA, Martin SG.

Radiother Oncol. 2011 Aug;100(2):308-13. doi: 10.1016/j.radonc.2011.05.029.

PMID:
21641069
19.

Calpastatin is associated with lymphovascular invasion in breast cancer.

Storr SJ, Mohammed RA, Woolston CM, Green AR, Parr T, Spiteri I, Caldas C, Ball GR, Ellis IO, Martin SG.

Breast. 2011 Oct;20(5):413-8. doi: 10.1016/j.breast.2011.04.002.

PMID:
21531560
20.

The calpain system and cancer.

Storr SJ, Carragher NO, Frame MC, Parr T, Martin SG.

Nat Rev Cancer. 2011 May;11(5):364-74. doi: 10.1038/nrc3050. Review.

PMID:
21508973

Supplemental Content

Loading ...
Support Center